HiRO Acquires U.S.-Based CRO Courante Oncology
Harvest Integrated Research Organization (HiRO) announced its acquisition of Courante Oncology, a full-service clinical research organization (CRO) based in Excelsior, Minnesota. According to data captured in the LevinPro HC database, this transaction represents the 26th CRO acquisition of the year. Courante Oncology provides clinical research consulting and services to pharmaceutical and medical device companies that are developing oncology products. HiRO is a CRO based in Shanghai, China. With global operations and integration capabilities, it provides a range of solutions and services to its clients, including early pre-clinical strategic planning, clinical trial design,... Read More »
Healthcare Subsectors Drive Double-Digit M&A Decline in 2023
There is no shortage of subsectors contributing to the overall double-digit percentage decline in healthcare M&A activity in 2023. According to the LevinPro HC database, there have been 1,299 healthcare M&A deals this year through July 31. This represents an 12% drop compared with the 1,481 transactions recorded during the same period in 2022. The 2023 total represents a 5% increase from the 1,240 deals posted in 2021 through July 31. Some of the subsectors that have contributed to the M&A activity decline this year include Contract Development Manufacturing Organizations (CDMO), healthcare staffing firms, infusion services companies, primary & value-based care... Read More »
RQM+ Acquires Germany-Based CRO Kottmann
RQM+ announced on August 28 its acquisition of CRO Kottmann for an undisclosed price. According to data captured in the LevinPro HC database, this transaction marks the 25th contract research organization (CRO) acquisition of 2023. CRO Kottmann is an international CRO based in Germany. The company conducts clinical studies with medical devices, in vitro diagnostics and pharmaceuticals. In addition to full service, CRO Kottmann also offers individual services such as the creation of databases, statistical evaluations and clinical monitoring for studies. RQM+ provides regulatory and quality solutions that accelerate the success of medical device companies. The company also... Read More »
Kohlberg to Acquire Majority Stake in Worldwide Clinical Trials
An affiliate of Kohlberg & Company, LLC has entered into a definitive agreement to acquire a majority stake in Worldwide Clinical Trials (WCT), in partnership with WCT’s management team. Following the sale to Kohlberg, WCT’s former owner, The Jordan Company, will retain a meaningful minority equity stake in the company. WCT is a full-service contract research organization (CRO) focused on CNS, cardiovascular, metabolic, immune-mediated inflammatory disorders, oncology and rare diseases. Its global footprint spans nearly 60 countries with more than 3,200 team members. Kohlberg & Company LLC is a private equity firm specializing in add-on acquisitions, follow-on acquisitions,... Read More »